Daniel Alkon

Daniel Alkon

President presso NEUROTROPE, INC.

Patrimonio netto: 6 683 $ in data 31/03/2024

81 anni
Health Technology
Consumer Services
Electronic Technology

Profilo

Daniel L.
Alkon
is currently the President, Director & Chief Scientific Officer at Synaptogenix, Inc. and the President & Chief Scientific Officer at Neurotrope, Inc. He previously worked as the Scientific Director & Professor at Blanchette Rockefeller Neurosciences Institute from 1999 to 2016.
He also served as the Medical Director at the National Institute of Neurological Disorders & Stroke.
Additionally, he worked as a Principal at Adaptive Systems, Inc. and as a Professor-Neurology at West Virginia University.
Dr. Alkon received his undergraduate degree from the University of Pennsylvania in 1965 and his doctorate from Cornell University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
25/03/2024 35 547 ( 0.17% ) 6 683 $ 31/03/2024

Posizioni attive di Daniel Alkon

SocietàPosizioneInizio
NEUROTROPE, INC. President 19/09/2016
SYNAPTOGENIX, INC. President -
Tutte le posizioni attive di Daniel Alkon

Precedenti posizioni note di Daniel Alkon

SocietàPosizioneFine
Chief Tech/Sci/R&D Officer 23/09/2016
West Virginia University Corporate Officer/Principal 01/09/2016
Corporate Officer/Principal -
National Institute of Neurological Disorders & Stroke Chief Tech/Sci/R&D Officer -
Vedi nel dettaglio l'esperienza di Daniel Alkon

Formazione di Daniel Alkon

University of Pennsylvania Undergraduate Degree
Cornell University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Daniel Alkon

Relazioni

100 +

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
SYNAPTOGENIX, INC.

Health Technology

Aziende private4

Health Technology

Electronic Technology

Health Technology

National Institute of Neurological Disorders & Stroke

Government

Vedi le connessioni aziendali